Blackrock’s Sending THIS Crypto Higher on Purpose

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Veronique Lecault net worth and biography

Veronique Lecault Biography and Net Worth

COO of AbCellera Biologics

Véronique Lecault is Co-founder, Chief Operating Officer and member of the Board of Directors at AbCellera. She received her PhD in Chemical and Biological Engineering from the University of British Columbia, where she co-invented the high-throughput microfluidic platform that is now part of AbCellera’s core technology. A strong advocate of entrepreneurship, science and technology, Véronique was recently recognized as a STEM Star Influencer by BCBusiness and as one of Canada’s Top 40 Under 40. She holds a B.A.Sc. in Chemical Engineering/Honours B.Sc. Biochemistry (Biotechnology) dual degree from the University of Ottawa and is a recipient of the L’Oreal-UNESCO For Women in Science Mentorship Award

What is Veronique Lecault's net worth?: The estimated net worth of Veronique Lecault is at least $4.89 million as of May 16th, 2022. Dr. Lecault owns 1,770,122 shares of AbCellera Biologics stock worth more than $4,885,537 as of November 23rd. This net worth estimate does not reflect any other investments that Dr. Lecault may own. Additionally, Dr. Lecault receives an annual salary of $650,590.00 as COO at AbCellera Biologics. Learn More about Veronique Lecault's net worth.
How old is Veronique Lecault?: Dr. Lecault is currently 39 years old. There are 5 older executives and no younger executives at AbCellera Biologics. The oldest executive at AbCellera Biologics is Mr. Tryn T. Stimart Esq., J.D., M.Sc., Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer, who is 54 years old. Learn More on Veronique Lecault's age.
What is Veronique Lecault's salary?: As the COO of AbCellera Biologics Inc., Dr. Lecault earns $650,590.00 per year. There are 4 executives that earn more than Dr. Lecault. The highest earning executive at AbCellera Biologics is Dr. Carl L.G. Hansen Ph.D., CEO, President & Chairperson, who commands a salary of $714,940.00 per year. Learn More on Veronique Lecault's salary.
How do I contact Veronique Lecault?: The corporate mailing address for Dr. Lecault and other AbCellera Biologics executives is , , . AbCellera Biologics can also be reached via phone at 604-559-9005 and via email at [email protected]. Learn More on Veronique Lecault's contact information.
Has Veronique Lecault been buying or selling shares of AbCellera Biologics?: Veronique Lecault has not been actively trading shares of AbCellera Biologics during the past quarter. Most recently, on Monday, May 16th, Veronique Lecault bought 200,000 shares of AbCellera Biologics stock. The stock was acquired at an average cost of $6.34 per share, with a total value of $1,268,000.00. Following the completion of the transaction, the chief operating officer now directly owns 1,770,122 shares of the company's stock, valued at $11,222,573.48. Learn More on Veronique Lecault's trading history.
Who are AbCellera Biologics' active insiders?: AbCellera Biologics' insider roster includes Andrew Booth (CFO), John Hamer (Director), Carl Hansen (CEO), Michael Hayden (Director), Veronique Lecault (COO), Andrew Lo (Director), and John Montalbano (Director). Learn More on AbCellera Biologics' active insiders.

Veronique Lecault Insider Trading History at AbCellera Biologics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/16/2022	Buy	200,000	$6.34	$1,268,000.00	1,770,122
2/28/2022	Buy	230,789	$8.66	$1,998,632.74
6/9/2021	Sell	1,000,000	$25.50	$25,500,000.00	1,006,000

Veronique Lecault Buying and Selling Activity at AbCellera Biologics

AbCellera Biologics Company Overview

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Today's Range

Now: $2.76

$2.71

$2.83

50 Day Range

MA: $2.69

$2.44

$3.15

2 Week Range

Now: $2.76

$2.34

$6.05

Volume

1,802,860 shs

Average Volume

1,696,099 shs

Market Capitalization

$815.21 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.35

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Veronique Lecault Biography and Net Worth

What is Veronique Lecault's net worth?

How old is Veronique Lecault?

What is Veronique Lecault's salary?

How do I contact Veronique Lecault?

Has Veronique Lecault been buying or selling shares of AbCellera Biologics?

Who are AbCellera Biologics' active insiders?